Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Pulmonary Complications after COVID-19

P. Jakubec, K. Fišerová, S. Genzor, M. Kolář

. 2022 ; 12 (3) : . [pub] 20220228

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22009906

Grantová podpora
DRO FNOL 00098892 University Hospital Olomouc
IGA_LF_2022_018 Palacký University Olomouc
AZV NU22-B-112 Czech Health Research Council

Coronavirus disease 2019 (COVID-19) is a threat to patients not only because of its acute course, but also because of various complications occurring in the following period, that is, more than 28 days after the onset of acute infection. The present study identified a total of 121 patients hospitalized 29 or more days after the first positive result of a PCR test for SARS-CoV-2, of whom 98 patients were included in the study. Patients were divided into two groups by the time interval between the positive COVID-19 test result and hospitalization date. The time intervals were week 5-11 in an ongoing-COVID group (57.1% of patients) and 12 or more weeks in a post-COVID-group (42.9%). The most frequent reason for hospitalization was respiratory tract infection (58.2%). Pneumonia accounted for 77.2% of these cases. Other reasons for hospitalization were interstitial lung disease (22.4%), pulmonary embolism (8.2%), and sarcoidosis (6.1%). The study group was further divided according to the causes of hospitalization into subgroups with infections and other causes. In the group with infectious diseases, there was a shorter time period between PCR positivity and hospitalization and there were significantly more frequent non-respiratory complications. In the entire sample, the in-hospital mortality was 5.1%.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22009906
003      
CZ-PrNML
005      
20220425131622.0
007      
ta
008      
220420s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/life12030357 $2 doi
035    __
$a (PubMed)35330108
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Jakubec, Petr $u Department of Pulmonary Diseases and Tuberculosis, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 77900 Olomouc, Czech Republic $u Department of Pulmonary Diseases and Tuberculosis, University Hospital Olomouc, I. P. Pavlova 185/6, 77900 Olomouc, Czech Republic $1 https://orcid.org/0000000261845731
245    10
$a Pulmonary Complications after COVID-19 / $c P. Jakubec, K. Fišerová, S. Genzor, M. Kolář
520    9_
$a Coronavirus disease 2019 (COVID-19) is a threat to patients not only because of its acute course, but also because of various complications occurring in the following period, that is, more than 28 days after the onset of acute infection. The present study identified a total of 121 patients hospitalized 29 or more days after the first positive result of a PCR test for SARS-CoV-2, of whom 98 patients were included in the study. Patients were divided into two groups by the time interval between the positive COVID-19 test result and hospitalization date. The time intervals were week 5-11 in an ongoing-COVID group (57.1% of patients) and 12 or more weeks in a post-COVID-group (42.9%). The most frequent reason for hospitalization was respiratory tract infection (58.2%). Pneumonia accounted for 77.2% of these cases. Other reasons for hospitalization were interstitial lung disease (22.4%), pulmonary embolism (8.2%), and sarcoidosis (6.1%). The study group was further divided according to the causes of hospitalization into subgroups with infections and other causes. In the group with infectious diseases, there was a shorter time period between PCR positivity and hospitalization and there were significantly more frequent non-respiratory complications. In the entire sample, the in-hospital mortality was 5.1%.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Fišerová, Kateřina $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 77900 Olomouc, Czech Republic
700    1_
$a Genzor, Samuel $u Department of Pulmonary Diseases and Tuberculosis, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 77900 Olomouc, Czech Republic $u Department of Pulmonary Diseases and Tuberculosis, University Hospital Olomouc, I. P. Pavlova 185/6, 77900 Olomouc, Czech Republic
700    1_
$a Kolář, Milan $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 77900 Olomouc, Czech Republic $1 https://orcid.org/0000000346218868 $7 jn20010310083
773    0_
$w MED00186366 $t Life (Basel, Switzerland) $x 2075-1729 $g Roč. 12, č. 3 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35330108 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220420 $b ABA008
991    __
$a 20220425131620 $b ABA008
999    __
$a ind $b bmc $g 1784435 $s 1161104
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 12 $c 3 $e 20220228 $i 2075-1729 $m Life $n Life (Basel) $x MED00186366
GRA    __
$a DRO FNOL 00098892 $p University Hospital Olomouc
GRA    __
$a IGA_LF_2022_018 $p Palacký University Olomouc
GRA    __
$a AZV NU22-B-112 $p Czech Health Research Council
LZP    __
$a Pubmed-20220420

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...